Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 12/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 9/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.38 |
| ▸ | MTOR | P42345 | 3/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.38 |
| ▸ | PIK3C2B | O00750 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31601874 | 0.91 | DGAT1 (0.40) | DGAT1SOAT1KDM4EPIK3CDMTOR | |
| SCHEMBL31602029 | 0.81 | THRB (0.39) | DGAT1SOAT1NAPEPLD | |
| SCHEMBL31601832 | 0.80 | PDE1B (0.36) | DGAT1SOAT1KDM4EPOLBNAPEPLD | |
| SCHEMBL31601938 | 0.80 | THRB (0.36) | DGAT1SOAT1KDM4EPOLBNAPEPLD | |
| SCHEMBL31601720 | 0.78 | THRB (0.36) | DGAT1SOAT1KDM4ENAPEPLD | |
| SCHEMBL31601824 | 0.76 | ABCB1 (0.31) | MTOR | |
| SCHEMBL31601743 | 0.76 | PIK3CD (0.38) | DGAT1SOAT1KDM4EPIK3CDPOLB | |
| SCHEMBL31601915 | 0.75 | CETP (0.31) | KDM4EMTORCETP | |
| SCHEMBL31601780 | 0.75 | PIK3CD (0.39) | DGAT1SOAT1PIK3CDMTORPIK3CG | |
| SCHEMBL31601753 | 0.74 | DGAT1 (0.34) | DGAT1SOAT1PIK3CDMTORPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110815-A1 | IMIDAZO [1,2-B] PYRIDAZINE-BASED NOVEL COMPOUND AS CDK INHIBITOR AND USE THEREOF | 아이리드비엠에스 주식회사 | 2025-05-30 | — | — | WO | disclosed |